Stocks股票 / Health Care / BMRN
BioMarin Pharmaceutical · Health Care
BMRN US listed · USD美股 · 美元
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California.BioMarin Pharmaceutical Inc.是一家美国生物技术公司，总部位于加利福尼亚州圣拉斐尔。
Large cap大盘 · $11B
Broken growth成长受损
Health Care
S&P 400标普400中盘
$59.11
-$0.48 · -0.81%
52w low52周低 $48.79high高 $64.88
Lagging — relative weakness落后 — 相对弱势
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum is rolling over — momentum is fading before the…筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已开始掉头向下——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Engine read引擎解读 · 2026-07-21
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量（RSI 14）
56
Neutral zone中性区域
vs 50-day average相对50日均线
+5.7% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+5.5% above上方
Long trend up长期向上
Volatility波动率
12th percentile第12百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-08-0314days to go天后公布
Estimates being cut预期下调
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | BMRN | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 32.58x | 28.59 | |
| P/B市净率 | 1.87x | 3.44 | |
| P/S市销率 | 3.53x | 2.97 | |
| Earnings yield盈利收益率 | 3.07% | 2.72 | |
| FCF yield自由现金流收益率 | 6.38% | 4.00 | |
| EV/EBITDA企业价值/EBITDA | 20.56x | 18.18 | |
| P/FCF市值/自由现金流 | 15.68x | 22.08 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
5-yr growth5年复合增速 11.6%
Earnings per share每股收益
5-yr growth5年复合增速 -16.9%
Free cash flow自由现金流
Operating margin营业利润率
12.7%
Net margin净利率
10.8%
FCF margin自由现金流利润率
25.7%
Balance-sheet quality财务体质 4/8
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 6%
Watch关注
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-2.68
Current ratio流动比率5.21
Capital allocation资本配置
Stock-based comp股权薪酬$181.4M
Share count change (1y)股数变化（1年）+0.8%
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +11.1%空头仓位变动 +11.1%
Technical技术面
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$3.0M net (0 buyers, 3 sellers)-$3.0M 净值（0 买家，3 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | Adding加仓 | 1.1% | 2026-03-31 |
Signal history信号历史
engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. Buyers rejected the 2026-06-18 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all买入预备。买方拒绝了 2026-06-18 的低点（摆动低点已现），但价格尚未收复 10 日均线——第一项条件达成，并非全部
Jul 16, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 16, 2026
BMRN StochRSI turned up from oversoldBMRN StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $60.00.StochRSI重回20上方 — 下行动量趋缓的最早预警。$60.00。
Jul 15, 2026
BMRN daily MACD crossed downBMRN 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $58.95.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$58.95。
Jul 14, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 13, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jul 9, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Jul 6, 2026
BOTTOMING → BUY ZONE筑底中 → 买入区
BUY买入
Jul 2, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Showing the last 15 of显示最近15条，共 260 signals条信号
Company profile公司档案
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California.BioMarin Pharmaceutical Inc.是一家美国生物技术公司，总部位于加利福尼亚州圣拉斐尔。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Above market高于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Above market高于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
- Receivables stretch
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 32.6× | 28.6× | 41% |
| Price / Book市净率 | 1.9× | 3.4× | 78% |
| Price / Sales市销率 | 3.5× | 3.0× | 42% |
| EV / EBITDAEV/EBITDA | 20.6× | 18.2× | 41% |
| Earnings yield盈利收益率 | 3.1% | 2.7% | 56% |
| Free-cash-flow yield自由现金流收益率 | 7.3% | 5.5% | 71% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
30/100 — weaker than most弱于多数
vs market, 3 months相对大盘（3个月）
59/100 — middle of the pack居中
vs market, 6 months相对大盘（6个月）
50/100 — middle of the pack居中
vs market, 12 months相对大盘（12个月）
33/100 — middle of the pack居中
Rank in sector行业内排名
#107 / 165
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -0.2% | -0.9% |
| 1 Month近1月 | +8.1% | -0.6% |
| 3 Months近3月 | +8.2% | +5.4% |
| 6 Months近6月 | +4.1% | +8.6% |
| Year to date年初至今 | -0.6% | +8.9% |
| 1 Year近1年 | +3.2% | +19.2% |
| 3 Years近3年 | -32.6% | +69.9% |
Trading information交易信息
Beta vs market贝塔
0.39
Volatility rank波动率分位
12th pctile
Short interest空头占比
7.2% of float
Market cap市值
$11B
EPS (trailing)每股收益
$1.81
Off 52-week high距52周高点
-7.8%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $1.9B | $1.8B | $2.1B | $2.4B | $2.9B | $3.2B |
| EPS每股收益 | $4.53 | $-0.35 | $0.75 | $0.87 | $2.21 | $1.80 |
| Free cash flow自由现金流 | $-29M | $209M | $55M | $63M | $487M | $725M |
| Gross margin毛利率 | 71.8% | 74.5% | 76.9% | 78.7% | 79.7% | 77.7% |
| Net margin净利率 | 46.2% | -3.5% | 6.8% | 6.9% | 15.0% | 10.8% |
| FCF margin自由现金流利润率 | -1.6% | 11.3% | 2.6% | 2.6% | 17.1% | 22.5% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$3.2B
Net income净利润
$349M
Operating cash flow经营现金流
$828M
Total assets总资产
$7.6B
Shareholder equity股东权益
$6.1B
Shares outstanding总股本
0.19B
Returns & growth回报与增长
Return on equity股本回报率
5.7%
Return on assets资产回报率
4.6%
Profit growth利润增速
-18.3%
Asset growth资产增速
+8.7%
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量：盈利有现金支撑
- Working capital: receivables +103% vs sales +73% — receivables outpacing sales, revenue-quality risk营运资本：应收 +103% 对销售 +73%——应收快于销售，营收质量风险
- Pricing power: gross margin +5.9pts over 6 years定价能力：毛利率 6 年上升 5.9 个百分点
- Capital discipline: share count +5.8% over 6 years (dilution)资本纪律：股本 6 年增加 5.8%（稀释）
- Balance sheet: Altman Z 5.66 — safe zone资产负债表：Altman Z 5.66——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
56
RSI (2-day)RSI（2日）
30
vs 20-day average相对20日均线
+0.9%
vs 50-day average相对50日均线
+5.7%
vs 200-day average相对200日均线
+5.5%
Golden cross (50>200)金叉（50>200）
not in effect未生效
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum up动能向上
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
29/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Estimate revisions预期修正
Analysts covering覆盖分析师
1
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
-4.1%
Net upgrades, 30 days净上调（30天）
-1
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | Adding增持 | 1.1% | $399M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
1 : 0
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 14, 'holders_first': 3, 'holders_last': 0, 'holders_delta': -3, 'value_change_pct': -100.0, 'from_period': '2023-03-31', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2023-05-15', 'holders_series': [3, 3, 2, 3, 3, 3, 2, 2, 2, 1, 1, 1, 1, 0]}{'direction': 'distributing', 'n_quarters': 14, 'holders_first': 3, 'holders_last': 0, 'holders_delta': -3, 'value_change_pct': -100.0, 'from_period': '2023-03-31', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2023-05-15', 'holders_series': [3, 3, 2, 3, 3, 3, 2, 2, 2, 1, 1, 1, 1, 0]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$3.0M
Insider buyers vs sellers内部人买家vs卖家
0 : 3
Short interest空头占流通盘
7.2%
Days to cover回补天数
6.0
Short interest change空头变化
+11.1%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Jul · 100%
Weakest month最弱月份
Jan · 0%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 0% | -4.7% | 3 |
| Feb2月 | 67% | +9.0% | 3 |
| Mar3月 | 33% | -0.5% | 3 |
| Apr4月 | 0% | -7.2% | 3 |
| May5月 | 33% | -7.1% | 3 |
| Jun6月 | 50% | +0.3% | 4 |
| Jul7月 | 100% | +3.4% | 4 |
| Aug8月 | 100% | +4.1% | 3 |
| Sep9月 | 0% | -7.0% | 3 |
| Oct10月 | 0% | -6.3% | 3 |
| Nov11月 | 100% | +4.7% | 3 |
| Dec12月 | 67% | +6.0% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。